Grifols appoints Montse Ribas as Chief Communications and Reputation Officer to strengthen the company's global reputation

Barcelona, Spain, April 3, 2025 - Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced it has named Montse Ribas Chief Communications and Reputation Officer. This appointment represents a strategic move for Grifols, which seeks to expand the company's awareness and further enhance its global reputation. As Chief Communications and Reputation Officer, Montse Ribas will prioritize strengthening trust with stakeholders and underscoring the company's excellence and vision. Her responsibilities include global communications and reputation management, as well as the definition and implementation of the strategy for institutional relations.

Montse Ribas has led corporate communications, communications and reputation strategy, and institutional relations for Puig in Spain for the past 25 years. She holds a degree in Business Administration and two master's degrees from ESADE in Business Management and Corporate Communication. Her extensive background covers media relations, crisis communications, corporate transformation and the organization of major institutional events.

"I am delighted to welcome a renowned professional like Montse Ribas, who has had an outstanding and successful career,” said Grifols CEO Nacho Abia. “Her deep knowledge of reputation management, communications and institutional relations, together with her extensive experience, will be decisive for Grifols. With her excellent experience and strategic mindset, I am convinced that she will do a great job to ensure Grifols' ongoing leadership in plasma medicines and diagnostic solutions.”

Montse Ribas is excited for the future with the company. "I am proud to be part of a global standout such as Grifols, with 115 years of commitment to the well-being of people,” Ribas said. “Grifols is a pioneering company that has helped create the plasma-derivatives industry, positioning itself as a top-three player. I am committed to promoting Grifols’ vision and conveying to all stakeholders the important contributions the company makes to people’s health as well as its work to achieve the privileged position it occupies today in the global healthcare industry.”